Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Colombo N, Gadducci A, Landoni F, Lorusso D, Sabbatini R, Artioli G, Berardi R, Ceccherini R, Cecere SC, Cormio G, De Angelis C, Legge F, Lissoni A, Mammoliti S, Mangili G, Naglieri E, Petrella MC, Ricciardi GRR, Ronzino G, Salutari V, Sambataro D, Savarese A, Scandurra G, Tasca G, Tomao F, Valabrega G, Zavallone L, Pignata S. Colombo N, et al. Among authors: tomao f. Gynecol Oncol. 2023 Aug;175:182-189. doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22. Gynecol Oncol. 2023. PMID: 37355448
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
Vici P, Fabi A, Metro G, Sergi D, Giannarelli D, Di Lauro L, Bepler G, Tomao F, Cognetti F, Conti F, Lopez M. Vici P, et al. Among authors: tomao f. Cancer Chemother Pharmacol. 2011 Mar;67(3):687-93. doi: 10.1007/s00280-010-1369-y. Epub 2010 May 29. Cancer Chemother Pharmacol. 2011. PMID: 20512334 Clinical Trial.
[Specificity of action of anticancer agents].
Vici P, Sergi D, Pizzuti L, Vincenzoni C, Vizza E, Tomao F, Morace N, Toglia G, Mancini E, Baiocco E, Di Lauro L, Botti C, Sindico S, Lopez M. Vici P, et al. Among authors: tomao f. Clin Ter. 2011;162(2):137-49. Clin Ter. 2011. PMID: 21533321 Italian.
Breast cancer risk after exposure to fertility drugs.
Lo Russo G, Spinelli GP, Tomao S, Rossi B, Frati L, Panici PB, Vici P, Codacci Pisanelli G, Tomao F. Lo Russo G, et al. Among authors: tomao s, tomao f. Expert Rev Anticancer Ther. 2013 Feb;13(2):149-57. doi: 10.1586/era.12.181. Expert Rev Anticancer Ther. 2013. PMID: 23406556 Review.
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
Vici P, Sergi D, Pizzuti L, Mariani L, Arena MG, Barba M, Maugeri-Saccà M, Vincenzoni C, Vizza E, Corrado G, Paoletti G, Tomao F, Tomao S, Giannarelli D, Di Lauro L. Vici P, et al. Among authors: tomao s, tomao f. J Exp Clin Cancer Res. 2013 Aug 8;32(1):49. doi: 10.1186/1756-9966-32-49. J Exp Clin Cancer Res. 2013. PMID: 23927758 Free PMC article. Clinical Trial.
Hot flushes in women with breast cancer: state of the art and future perspectives.
Barba M, Pizzuti L, Sergi D, Maugeri-Saccà M, Vincenzoni C, Conti F, Tomao F, Vizza E, Di Lauro L, Di Filippo F, Carpano S, Mariani L, Vici P. Barba M, et al. Among authors: tomao f. Expert Rev Anticancer Ther. 2014 Feb;14(2):185-98. doi: 10.1586/14737140.2013.856271. Epub 2013 Dec 6. Expert Rev Anticancer Ther. 2014. PMID: 24313623 Review.
Emerging biological treatments for uterine cervical carcinoma.
Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, Tomao F, Tomao S, Mancini E, Vincenzoni C, Barba M, Maugeri-Saccà M, Giovinazzo G, Venuti A. Vici P, et al. Among authors: tomao s, tomao f. J Cancer. 2014 Jan 5;5(2):86-97. doi: 10.7150/jca.7963. eCollection 2014. J Cancer. 2014. PMID: 24494026 Free PMC article. Review.
170 results